GenomeUp
Founded 2017 · 39 employees on LinkedIn · 9 known investors
Find your way into GenomeUp
200 people in our graph share verified history with the GenomeUp team — schools, employers, funds. One of them is your warm intro.
GenomeUp develops JuliaOmix™, an integrated software suite for genetic diagnostics covering patient management, sample tracking, genomic data analysis, and secure storage. It serves laboratories, research institutes, and healthcare facilities across Italy and Europe.
Founders & leadership
GenomeUp was founded in 2017 by Simone Gardini.

Investors · 9
How we know: CDP Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Lumen Ventures's portfolio page · tech.eu · Not right? Tell us
How we know: LVenture Group's portfolio page · funding news · Not right? Tell us
How we know: Scientifica Venture Capital's portfolio page · funding news · press coverage · Not right? Tell us
How we know: tech.eu · Not right? Tell us
How we know: tech.eu · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundFeb 2022
Lumen Ventures (lead), a|impact, Finalca, GCM Group, Padda Health
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through GenomeUp went on to found or lead other companies.
Frequently asked questions
- What does GenomeUp do?
- GenomeUp develops JuliaOmix™, an integrated software suite for genetic diagnostics covering patient management, sample tracking, genomic data analysis, and secure storage. It serves laboratories, research institutes, and healthcare facilities across Italy and Europe.
- Who founded GenomeUp?
- GenomeUp was founded by Simone Gardini in 2017.
- Who are GenomeUp's investors?
- GenomeUp's investors include CDP Venture Capital, Lumen Ventures, LVenture Group, Scientifica Venture Capital, a|impact, Finalca Srl, Lazio Innova.





